Quantcast
Connect with us

Ex-White House counsel John Dean explains why it ‘could be an act of obstruction’ if Trump team leaked Mueller’s questions

Published

on

John Dean, Former White House Counsel for United States President Richard Nixon (Photo: Screen capture)

Attorney Robert S. Mueller III, who is overseeing the Russians investigation into the 2016 presidential election released a list of four dozen questions his team wants to ask President Trump.

Former White House Counsel, John Dean, said the very act of releasing the questions is an obstruction of justice.

In an interview with CNN’s Anderson Cooper, Dean said: “the very fact that the questions are out there, my first reaction suggesting that it could be an act of obstruction justice.”

ADVERTISEMENT

He said is was an obstruction justice because it disrupts the proper flow of information.

“Well, to try to somehow disrupt the flow of information, the tipping off of witness in advance to what the question was going to be, and listening to — you are reading the questions, and I’m scanning them, it appears to me more that these are questions somebody wrote down after listening to someone else than necessarily the questions that were designed by the prosecutors.”

Watch his full interview with Cooper below.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump tax returns show he held a bank account in China — as he spent years pursuing business deals there: report

Published

on

On Tuesday, as part of their series on President Donald Trump's tax returns, The New York Times revealed that the president has held a previously unknown bank account in China, as he spent years pursuing business deals in the country.

"Mr. Trump’s own business history is filled with overseas financial deals, and some have involved the Chinese state," reported Mike McIntire, Russ Buettner, and Susanne Craig. "He spent a decade unsuccessfully pursuing projects in China, operating an office there during his first run for president and forging a partnership with a major government-controlled company."

Continue Reading

2020 Election

The FDA repeatedly stood up to Trump on coronavirus — and even won some victories: NYT

Published

on

President Donald J. Trump has repeatedly tried to undermine the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (F.D.A.) and now, with just two weeks until Election Day, the world is learning more about the behind-the-scenes battles that have shaken these governmental entities to the core.

Approximately two weeks after Trump's release from Walter Reed Medical Center, there is no "cure," as the president stated, and he is not "immune." No one is immune - and there is no successful vaccine, regardless of how much Trump claims one will arrive before Nov. 3. The F.D.A. published the guidelines in briefing materials to an advisory committee that will discuss them on Thursday, effectively making them official. To be clear, the F.D.A.has not approved Trump's miraculous cure of a cocktail - even though he has claimed differently.

Continue Reading
 

Breaking Banner

Lawmakers more optimistic on COVID stimulus as election day looms

Published

on

Chances for approving a new spending package to support the US economy improved dramatically on Tuesday after the senior Democratic lawmaker said a bill is in the works and the top Senate Republican said he would bring it to a vote.

US House Speaker Nancy Pelosi said on Bloomberg TV that legislators are starting to commit the measure to paper and she is optimistic it can win bipartisan support.

Whether policymakers can complete the negotiations in time for Congress to approve the package before the November 3 presidential election, however, remains a question mark.

"Our economy needs it. Hopefully by the end of the day today, we will know where we are," she said in an interview. "We are starting to write the bill."

Continue Reading
 
 
Democracy is in peril. Invest in progressive news. Join Raw Story Investigates for $1. Go ad-free. LEARN MORE